Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Tirzepatide (Mounjaro) was approved in May 2022 for adults with type 2 diabetes, with the brand name Zepbound approved in November 2023 for obesity
share high obesity rates and a "strong uptake" in GLP-1 drugs, the researchers noted in a press release
#FunctionalMedicine #GLP1 #LCarnitine #CompoundingPharmacy #WeightLossSupport #MetabolicHealth #PatientCare To view or add a comment, sign in More Relevant Posts
PlexusDx Tirzepatide Injection is $289/mo month-to-month (or $249/mo on the 6-month plan), with pricing flat across all dose levelsyour dose may need to go up, but your price won't
US$ 23.80
)
US$ 25.29
US$ 28.04
US$ 22.00
